90 related articles for article (PubMed ID: 17276397)
1. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
[TBL] [Abstract][Full Text] [Related]
2. Expression of C-terminal deleted p53 isoforms in neuroblastoma.
Goldschneider D; Horvilleur E; Plassa LF; Guillaud-Bataille M; Million K; Wittmer-Dupret E; Danglot G; de Thé H; Bénard J; May E; Douc-Rasy S
Nucleic Acids Res; 2006; 34(19):5603-12. PubMed ID: 17028100
[TBL] [Abstract][Full Text] [Related]
3. DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.
Takahashi M; Ozaki T; Takahashi A; Miyauchi M; Ono S; Takada N; Koda T; Todo S; Kamijo T; Nakagawara A
Oncogene; 2007 Aug; 26(38):5669-73. PubMed ID: 17353905
[TBL] [Abstract][Full Text] [Related]
4. Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents.
Gangopadhyay S; Jalali F; Reda D; Peacock J; Bristow RG; Benchimol S
Exp Cell Res; 2002 Apr; 275(1):122-31. PubMed ID: 11925110
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
6. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells.
Lee SY; Kim JW; Jeong MH; An JH; Jang SM; Song KH; Choi KH
FEBS Lett; 2008 Aug; 582(19):2826-32. PubMed ID: 18656471
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
8. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
[TBL] [Abstract][Full Text] [Related]
9. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
[TBL] [Abstract][Full Text] [Related]
10. The 7-amino-acid site in the proline-rich region of the N-terminal domain of p53 is involved in the interaction with FAK and is critical for p53 functioning.
Golubovskaya VM; Finch R; Zheng M; Kurenova EV; Cance WG
Biochem J; 2008 Apr; 411(1):151-60. PubMed ID: 18215142
[TBL] [Abstract][Full Text] [Related]
11. p53 determines multidrug sensitivity of childhood neuroblastoma.
Xue C; Haber M; Flemming C; Marshall GM; Lock RB; MacKenzie KL; Gurova KV; Norris MD; Gudkov AV
Cancer Res; 2007 Nov; 67(21):10351-60. PubMed ID: 17974978
[TBL] [Abstract][Full Text] [Related]
12. Determinants of the response of neuroblastoma cells to DNA damage: the roles of pre-treatment cell morphology and chemical nature of the damage.
Hartsell TL; Hinman LM; Hamann PR; Schor NF
J Pharmacol Exp Ther; 1996 May; 277(2):1158-66. PubMed ID: 8627528
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization signal of ING4 plays a key role in its binding to p53.
Zhang X; Wang KS; Wang ZQ; Xu LS; Wang QW; Chen F; Wei DZ; Han ZG
Biochem Biophys Res Commun; 2005 Jun; 331(4):1032-8. PubMed ID: 15882981
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions.
Mondal AM; Chinnadurai S; Datta K; Chauhan SS; Sinha S; Chattopadhyay P
Cancer Res; 2006 Nov; 66(21):10466-77. PubMed ID: 17079468
[TBL] [Abstract][Full Text] [Related]
15. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
16. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.
Blanco S; Klimcakova L; Vega FM; Lazo PA
FEBS J; 2006 Jun; 273(11):2487-504. PubMed ID: 16704422
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.
Tang X; Milyavsky M; Goldfinger N; Rotter V
Oncogene; 2007 Nov; 26(52):7302-12. PubMed ID: 17533371
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional upregulation of p19INK4d upon diverse genotoxic stress is critical for optimal DNA damage response.
Ceruti JM; Scassa ME; Marazita MC; Carcagno AC; Sirkin PF; Cánepa ET
Int J Biochem Cell Biol; 2009 Jun; 41(6):1344-53. PubMed ID: 19130897
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
Song YC; Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():26-34. PubMed ID: 17404014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
